Key result
V-LAP device facilitates remote cardiac care for advanced HF patients during the COVID-19 pandemic.
Answers are grounded in this paper and cite their sources.
Supports feasibility of V-LAP remote monitoring in advanced HF during crises; hypothesis-generating and requires prospective validation.
MF, Rosano G, Ruschitzka F, Volterrani M, Voors AA, Filippatos G, Coats AJ. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019;21: 1169–1186. 4. European Society of Cardiology (ESC). Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. 21 April 2020. https://www.escardio.org/Education/COVID-19and-Cardiology/ESC-COVID-19-Guidance (27 May 2020). 5. Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, Metra M. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail 2020;22: 957–966. 6. De Filippo O, D’Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, Secco GG, Campo G, Gallone G, Verardi R, Gaido L, Iannaccone M, Galvani M, Ugo F, Barbero U, Infantino V, Olivotti L, Mennuni M, Gili S, Infusino F, Vercellino M, Zucchetti O, Casella G, Giammaria M, Boccuzzi G, Tolomeo P, Doronzo B, Senatore G, Grosso Marra W, Rognoni A, Trabattoni D, Franchin L, Borin A, Bruno F, Galluzzo A, Gambino A, Nicolino A, Truffa Giachet A, Sardella G, Fedele F, Monticone S, Montefusco A, Omedè P, Pennone M, Patti G, Mancone M, De Ferrari GM. Reduced rate of hospital admissions for ACS during Covid19 outbreak in Northern Italy. N Engl J Med 2020;383:88–89. 7. Piccolo R, Bruzzese D, Mauro C, Aloia A, Baldi C, Boccalatte M, Bottiglieri G, Briguori C, Caiazzo G, Calabrò P, Cappelli-Bigazzi M, de Simone C, di Lorenzo E, Golino P, Monda V, Perrotta R, Quaranta G, Russolillo E, Scherillo M, Tesorio T, Tuccillo B, Valva G, Villari B, Tarantini G, Varricchio A, Esposito G. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak. Circulation 2020;141: 2035–2037. 8. Fraiche AM, Eapen ZJ, McClellan MB. Moving beyond the walls of the clinic: opportunities and challenges to the future of telehealth in heart failure. JACC Heart Fail 2017;5:297–304. 9. Gorodeski EZ, Goyal P, Cox ZL, Thibodeau JT, Reay RE, Rasmusson K, Rogers JG, Starling RC. Virtual visits for care of patients with heart failure in the era of COVID-19: a statement from the Heart Failure Society of America. J Card Fail 2020;26:448–456. 10. Cleland JG, Clark RA, Pellicori P, Inglis SC. Caring for people with heart failure and many other medical problems through and beyond the COVID-19 pandemic; the advantages of universalaccess to home telemonitoring. Eur J Heart Fail 2020;22:995–998.
No takes yet. Share an insight, caveat, or question.
D’Amario et al. (2020) studied Advanced Heart Failure. V-LAP™ Device was evaluated. The V-LAP device was discussed for remote cardiac care during the COVID-19 pandemic, but no quantitative study results were provided in the text.
Synapse has enriched 10 related papers. Consider them for comparative context: